Why everyone is mad about New York’s AI hiring law
By Tate Ryan-Mosley,
MIT Technology Review
| 07. 10. 2023
Last week, a law about AI and hiring went into effect in New York City, and everyone is up in arms about it. It’s one of the first AI laws in the country, and so the way it plays out will offer clues about how AI policy and debate might take shape in other cities. AI hiring regulation is part of the AI Act in Europe, and other states in the US are considering similar bills to New York’s.
The use of AI in hiring has been criticized for the way it automates and entrenches existing racial and gender biases. AI systems that evaluate candidates’ facial expressions and language have been shown to prioritize white, male, and abled-bodied candidates. The problem is massive, and many companies use AI at least once during the hiring process. US Equal Employment Opportunity Commission chair Charlotte Burrows said in a meeting in January that as many as four out of five companies use automation to make employment decisions.
NYC’s Automated Employment Decision Tool law, which came into force on Wednesday, says that...
Related Articles
By Vittoria Vardanega, SWI swissinfo.ch | 02.13.2026
In recent years, sperm donation has produced family trees of unprecedented size, stretching across countries and, in some cases, continents. Stories of “mass donors” have captured public attention, most recently through the Netflix documentary series, The Man with 1,000 Kids...
By Jonathan D. Moreno, Hastings Center Bioethics Forum | 02.09.2026
When I began to write a book about bioethics and the rules-based international order, the idea that the world was facing the greatest geopolitical change since World War II was uncontroversial for those who were paying attention to such esoterica...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...